Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

Allarity Therapeutics, Inc. ALLR

· Materials · Pharmaceutical Preparations

FY2025 10-K, filed 2026-03-30
SEC EDGAR

Filing evidence summary

Caution evidenceCoverage 3/5 core metrics

Latest reported free cash flow was -$15M.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Free cash flow was negative

    Latest reported free cash flow was -$15M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

  • 5 filing risk checks flagged

    Flagged areas: Earnings quality, Solvency & liquidity, Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

Core trend metrics

Latest annual operating margin
-3939.1%
as of 2025-12-31
Free cash flow
-$15M
as of 2025-12-31
ROIC snapshot
-160.0%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

5of 7 rule-based checks flagged
  • Earnings quality
  • Solvency & liquidity
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-03-30prior period 2024-12-31 from the same filingView filing
By product or service
Revenue
  • License$320K
    100.0%
    no prior

Members sum to the consolidated $320K for this period.

Latest quarter
Quarter ending 2026-03-3110-Q filed 2026-05-15prior period 2025-03-31 from the same filingView filing
  • License$25K
    100.0%
    no prior

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,122 US-listed filers · 797 in Materials
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$320000
2ndof 3,301
bottom third
6thof 522
bottom third
Operating margin
operating income ÷ revenue
-3939.1%
4thof 2,819
bottom third
12thof 483
bottom third
Net margin
net income ÷ revenue
-3509.7%
3rdof 3,263
bottom third
11thof 518
bottom third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
-4633.8%
2ndof 2,679
bottom third
8thof 433
bottom third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-114.3%
10thof 3,577
bottom third
22ndof 701
bottom third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
150.6%
5thof 2,895
bottom third
17thof 476
bottom third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
17.6%
3rdof 3,577
bottom third
6thof 673
bottom third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
-45.5%
89thof 3,059
top third
78thof 593
top third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-12-31 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
17.5%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
-45.5%
change in net operating assets ÷ average net operating assets
Cash-backed years
2 of 5
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 27 changed periods, 24 largest shown
Line itemPeriodFirst reportedLatest filingChangeFilings
Interest expense
InterestExpense
fiscal year 2022-12-31$12K
10-K 2023-03-13
$223K
10-K 2024-03-08
+1758.3%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2022-09-309,871,413 shares
10-Q 2022-11-14
7,153 shares
10-Q 2023-11-14
-99.9%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
fiscal year 2022-12-319,527,111 shares
10-K 2023-03-13
6,805 shares
10-K 2024-03-08
-99.9%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2023-03-31758,144 shares
10-Q 2023-05-11
528 shares
10-Q 2024-05-14
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2022-09-309,871,413 shares
10-Q 2022-11-14
7,153 shares
10-Q 2023-11-14
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
fiscal year 2022-12-319,527,111 shares
10-K 2023-03-13
6,805 shares
10-K 2024-03-08
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2023-03-31758,144 shares
10-Q 2023-05-11
528 shares
10-Q 2024-05-14
-99.9%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2023-09-302,474,724 shares
10-Q 2023-11-14
4,125 shares
10-Q 2024-11-14
-99.8%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
fiscal year 2023-12-311,990,748 shares
10-K 2024-03-08
3,385 shares
10-K 2025-03-31
-99.8%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2022-06-309,016,754 shares
10-Q 2022-10-07
120,223 shares
10-Q 2023-08-14
-98.7%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2022-06-309,016,754 shares
10-Q 2022-10-07
120,223 shares
10-Q 2023-08-14
-98.7%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2020-09-30194,948,069 shares
10-Q 2021-11-23
3,724,617 shares
10-Q/A 2022-05-17
-98.1%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2021-09-30397,201,067 shares
10-Q 2021-11-23
7,753,051 shares
10-Q 2022-11-14
-98.0%first · latest · 3 filings carry it
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2022-03-318,288,371 shares
10-Q 2022-05-27
236,811 shares
10-Q 2023-05-11
-97.1%first · latest
Total liabilities
Liabilities
balance at 2021-09-30$4.22M
10-Q 2021-11-23
$7.33M
10-Q/A 2022-05-17
+73.6%first · latest
Stock-based compensation
ShareBasedCompensation
quarter 2024-03-31-$121K
10-Q 2024-05-14
-$32K
10-Q 2025-05-09
+73.5%first · latest
Total liabilities
Liabilities
balance at 2020-12-31$6.55M
10-Q 2021-11-23
$8.96M
10-K 2022-05-17
+36.8%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
quarter 2021-09-30-$3.19M
10-Q 2021-11-23
-$3.97M
10-Q 2022-11-14
-24.5%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
quarter 2020-09-30-$1.97M
10-Q 2021-11-23
-$1.74M
10-Q/A 2022-05-17
+11.6%first · latest
Stockholders' equity
StockholdersEquity
balance at 2021-09-30$32.8M
10-Q 2021-11-23
$29.7M
10-Q 2022-11-14
-9.5%first · latest · 3 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2021-03-31$25.9M
10-Q 2021-11-23
$23.5M
10-Q 2022-11-14
-9.4%first · latest · 5 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2020-12-31$26.9M
10-Q 2021-11-23
$24.4M
10-K 2023-03-13
-9.0%first · latest · 7 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2020-09-30$24.7M
10-Q 2021-11-23
$22.7M
10-Q/A 2022-05-17
-7.8%first · latest
Stockholders' equity
StockholdersEquity
balance at 2020-06-30$22.7M
10-Q 2021-11-23
$21.4M
10-Q/A 2022-05-17
-6.1%first · latest

6 share-count periods re-presented for a stock split (1-for-50, 1-for-30, 1-for-20) are listed apart from restatements and not counted above.

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

Not available for ALLR yet: no footnote text blocks on file for this filer in the ingested DERA files.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.